KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Amortizatization of Intangibles (2020 - 2025)

AbCellera Biologics (ABCL) has disclosed Amortizatization of Intangibles for 6 consecutive years, with $941000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 98.72% year-over-year to $941000.0, compared with a TTM value of $3.7 million through Dec 2025, down 95.23%, and an annual FY2025 reading of $3.7 million, down 95.23% over the prior year.
  • Amortizatization of Intangibles was $941000.0 for Q4 2025 at AbCellera Biologics, roughly flat from $940000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $73.5 million in Q4 2024 and bottomed at -$30.0 million in Q3 2024.
  • Average Amortizatization of Intangibles over 5 years is $5.8 million, with a median of $1.7 million recorded in 2023.
  • Peak annual rise in Amortizatization of Intangibles hit 3276.71% in 2021, while the deepest fall reached 4093.42% in 2021.
  • Year by year, Amortizatization of Intangibles stood at $890000.0 in 2021, then skyrocketed by 1141.12% to $11.0 million in 2022, then crashed by 39.24% to $6.7 million in 2023, then skyrocketed by 995.2% to $73.5 million in 2024, then plummeted by 98.72% to $941000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for ABCL at $941000.0 in Q4 2025, $940000.0 in Q3 2025, and $577000.0 in Q2 2025.